Valneva SE Pref. Share Price Euronext Paris
Stocks
VLAP
FR0011472943
Biotechnology & Medical Research
OTC Markets Traded|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-.--% | - |
| 06-26 | European Medicines Agency Panel Recommends Change to Valneva's Chikungunya Vaccine Marketing Approval | MT |
| 06-26 | Valneva Appoints a New Chairman of the Board |
| Market Cap | 423M 483M 391M 365M 687M 45.71B 703M 4.7B 1.82B 22.55B 1.82B 1.78B 78.28B | P/E 2026 * |
-6.08x | P/E 2027 * | 5.87x |
|---|---|---|---|---|---|
| Enterprise Value | 551M 630M 509M 475M 895M 59.53B 915M 6.12B 2.36B 29.37B 2.36B 2.31B 102B | EV / Sales 2026 * |
3.63x | EV / Sales 2027 * | 1.64x |
| Free-Float |
97.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Valneva SE Pref.
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | - | |
Peter Buhler
DFI | Director of Finance/CFO | 56 | 28/07/2021 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 62 | 19/12/2023 | |
James Sulat
BRD | Director/Board Member | 75 | 06/03/2013 |
| Chairman | 65 | 19/12/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 483M | ||
| +0.94% | +7.83% | -4.50% | +3.17% | 46.2B | ||
| +2.80% | +12.12% | +405.33% | +609.04% | 38.71B | ||
| +0.05% | +13.76% | +21.14% | -13.78% | 31.9B | ||
| +2.73% | +5.53% | +18.49% | +60.60% | 31.12B | ||
| +8.02% | +5.23% | +17.67% | +35.36% | 23.77B | ||
| +0.34% | +14.22% | - | - | 16.2B | ||
| -0.06% | +15.30% | +67.39% | +123.62% | 15.05B | ||
| -1.13% | +7.40% | +12.81% | +20.67% | 13.74B | ||
| -0.46% | +6.29% | +104.15% | +96.21% | 13.42B | ||
| Average | +1.26% | +10.60% | +80.31% | +116.86% | 25.57B | |
| Weighted average by Cap. | +1.66% | +10.07% | +92.28% | +137.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 152M 173M 140M 131M 246M 16.39B 252M 1.69B 651M 8.09B 651M 637M 28.08B | 294M 336M 271M 253M 477M 31.75B 488M 3.27B 1.26B 15.66B 1.26B 1.23B 54.38B |
| Net income | -66.01M -75.39M -60.94M -56.91M -107M -7.13B -110M -733M -283M -3.52B -283M -277M -12.21B | 70.5M 80.52M 65.08M 60.78M 114M 7.61B 117M 783M 302M 3.76B 302M 296M 13.04B |
| Net Debt | 128M 146M 118M 110M 208M 13.82B 212M 1.42B 549M 6.82B 549M 537M 23.68B | 60.02M 68.54M 55.41M 51.74M 97.4M 6.48B 99.62M 667M 257M 3.2B 257M 252M 11.1B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VLA Stock
- VLAP Stock
Select your edition
All financial news and data tailored to specific country editions

















